ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A Supportive Membership Offer While You Plan Your Next Step
Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.
Qureight’s Fibr8 model to provide structural assessment as secondary endpoint in Contineum’s Phase 2 PROPEL-IPF clinical trial examining the safety and efficacy of PIPE-791 in idiopathic pulmonary fibrosis (IPF) patients
Read this season's news from One Nucleus and the wider ecosystem!
Guest post by Dmitry Bachin, PhD, Key Account Manager at SciSure | If you would like to submit a guest post please email [email protected]
Amsbio is a premier supplier of high-quality heparan sulfate (HS) monoclonal antibodies for use in brain and neurodegenerative research. In a recent published study** from Stanford University, these antibodies have been used to reveal a key role for endothelial glycocalyx degradation in aging and neurodegenerative disease.
Sandwich, UK — 4 November 2026: Discovery Park, Kent’s science and innovation hub, has launched the eighth edition of its Discovery Spark accelerator programme, welcoming 10 startups to its campus in Sandwich.
Join some of the Cambridge Network team and fellow members for an afternoon of networking over tea, cakes and fruit at our next quarterly Cambridge Network Connect networking event. If you want to meet like-minded companies and some new people, come and join us for a couple of hours. We’d love to meet you too.
No presentations, just some welcomes and introductions from our CEO, hosts and sponsors. Book early as these events are usually sold out.
Event timings are:
The Budget on 28 October 2026, the first under the new Prime Minister and John Healey’s first as Chancellor, left the rates of R&D tax relief unchanged and announced two changes to how claims are made. Companies making R&D claims on or after 1 April 2027 will no longer have to submit a Claim Notification Form, and the Additional Information Form will be simplified from autumn 2027. Alongside the Budget, HM Treasury opened a consultation on simplifying the corporate tax rules, R&D relief among them.
Bidwells' Creative Places team has appointed Sue Foxley and Harry Blevins, strengthening its research capability and London science and technology leasing offer as the business continues to grow.
Sue will be joining the Creative Places team on a part-time basis, to focus on leading edge research and data trends in science and technology as well as providing valuable insight to clients on ecosystem strategy through Creative Places consultancy mandates. Sue will continue to lead the Research function across the Bidwells Group.